Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Critical Thinking at the Bedside: Incorporating Uncertainty into your Practice and Teaching - April 24, 2020, 4/24/2020 8:00:00 AM - 4/24/2023 9:00:00 AM, Dr. Schwartzstein discusses patterns of thought processing for medical diagnosis. One is based on heuristic principles that allows for more efficient decision making but can lead to systemic errors, and another requiring deductive clinical reasoning and flexible hypothesis generation which is particularly useful in complex or unusual medical presentations. He supports questioning and innovation over speed for treatment decisions, which can lead to constructive discussions about uncertainty with colleagues and patients.
Presenter
Richard M. Schwartzstein, MD
Chief, Division of Pulmonary, Critical Care, and Sleep Medicine
Executive Director, Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center
Ellen and Melvin Gordon Professor of Medicine and Medical Education
About our presenter:
Dr. Richard Schwartzstein has been an active clinical educator and pursued both physiological and educational research while at Harvard Medical School. His education research focuses on the development of pedagogical approaches to enhance analytical reasoning, techniques to maximize the benefits of small group teaching, and assessment of the role of simulation in medical education.
Learning Outcome(s)
Participants will be able to describe a framework of thinking that includes System 1 and System 2 concepts, provide strategies for teaching thinking skills at the bedside, explain how explicit acknowledgement of uncertainty may enhance patient care, and describe strategies for discussing uncertainty with patients.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Presenter
Richard M. Schwartzstein, MD
Chief, Division of Pulmonary, Critical Care, and Sleep Medicine
Executive Director, Shapiro Institute for Education and Research at Harvard Medical School and Beth Israel Deaconess Medical Center
Ellen and Melvin Gordon Professor of Medicine and Medical Education
About our presenter:
Dr. Richard Schwartzstein has been an active clinical educator and pursued both physiological and educational research while at Harvard Medical School. His education research focuses on the development of pedagogical approaches to enhance analytical reasoning, techniques to maximize the benefits of small group teaching, and assessment of the role of simulation in medical education.
Learning Outcome(s)
Participants will be able to describe a framework of thinking that includes System 1 and System 2 concepts, provide strategies for teaching thinking skills at the bedside, explain how explicit acknowledgement of uncertainty may enhance patient care, and describe strategies for discussing uncertainty with patients.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
